Climb Bio
Climb Bio is seeking an experienced Senior Clinical Trial Manager to lead the end-to-end delivery of Phase 1–3 studies, with an immediate focus on Phase 1/Phase 2 execution and the development of scalable clinical operations processes. This role involves serving as the operational lead on project teams, managing trial conduct, inspection readiness, and vendor performance while ensuring compliance with GCP and quality standards. The position requires strong strategic planning, problem-solving abilities, and the capacity to work effectively in a fast-paced biotech environment.
Headquarters
Wellesley, Massachusetts, United States
Company Size
11-50 employees
Founded
2018
Climb Bio is a biopharmaceutical company focused on discovering and developing inspired medicines for immune‑mediated diseases. The team emphasizes uncovering overlooked biology and translating those insights into novel therapeutic candidates. With a results‑driven, science‑forward approach, Climb Bio aims to advance promising programs toward development to improve outcomes for patients with immune‑driven conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Climb Bio.
Climb Bio didn’t post a salary, so this is our estimate from similar listings.